Uribesalgo et al. recently showed that apelin ablation enhances effectiveness of anti-angiogenic treatment in preclinical models of mammary and lung cancer and, furthermore, that blocking apelin prevents sunitinib-induced metastases. The gene discussed is APLN; the disease is lung carcinoma.